This meeting is being held in accordance with the corporation's bylaws and Delaware law. Our meeting today will take care of the formal business at hand, which is described in our Notice and Proxy Statement, a copy of which was mailed on or about August 16, 2023, to all of our shareholders of record at the close of business on August 11, 2023. During this portion of the meeting, all discussion will be limited to the official business at hand. Before proceeding to the formal business, I'd like to introduce the directors and officers of the corporation who are with us today. Our outside directors are David Drutz, MD; John M. Gill; Philip Hodges; Diane Jorkasky, MD; Wayne Pisano; Klaus Schafer, MD, and Catherine Sohn, PharmD.
Our officers are Vipin Garg, PhD, President and Chief Executive Officer, Richard Eisenstadt, MBA, Chief Financial Officer, Scot Roberts, PhD, Chief Scientific Officer, Scott Harris, MD, Chief Medical Officer, Raymond M. Jordt, Chief Business Officer. Thank you. Our independent auditors, the firm of Ernst & Young LLP, is represented at this meeting by Jennifer Totte. Our outside counsel, the firm of Goodwin Procter LLP, is represented by Joseph Theis. Thank you. Now let's proceed to the formal business of the meeting, notice of which was sent to all shareholders of record as of the close of business on August eleventh, two thousand twenty-three. Shareholders of record on that date are entitled to vote at this meeting. We have, at this meeting, a record of stockholders as of that date.
A duplicate record has been on file at the principal place of business of the corporation for the last 10 days, immediately prior to the date of this meeting, and has been available for inspection by any stockholder during that period at any time during normal business hours. If any stockholder wishes to address the chairman during the formal part of this meeting, please do so by entering your question in the text box provided on the web portal. I request that your comments be brief in order to allow other stockholders the opportunity to ask questions or provide comments and proposal under consideration. If you have any questions on the rules of conduct of the meeting, we have posted the rules of conduct to the web portal.
The board of directors has appointed Kristen Figueroa, who is joining the meeting telephonically, to act as Inspector of Election for this annual meeting, and she will tabulate results of the voting. The Inspector of Election has signed the oath of her office, which will be filed with the minutes of this meeting. Mrs. Figueroa, do we have a quorum present?
Mr. Chairman, of the 52,686,426 shares of Common Stock entitled to vote at the meeting, 34,561,978 shares are represented, either in person or by proxy, and therefore a quorum is present.
Thank you. I declare that a quorum is present. We may now proceed to transact the business for which this meeting has been called. Let me briefly describe the voting procedures. We'll vote by proxy and by written ballot via the web portal. If you have previously turned in your proxy and you do not intend to change your vote, it is not necessary that you complete another proxy or ballot. Your vote will be counted. If you are eligible to vote and have not submitted your proxy, or if you want to change your vote, please submit your vote via the voting buttons on the web portal. It is now 8:34 A.M. on September 28th, 2023, and the polls for each matter to be voted on at this annual meeting are now open. Our first item of business is the election of directors.
At this meeting, we will be voting on nine nominees for director to serve for a term of one year, all as set forth in the proxy statement. In accordance with the bylaws, your directors have nominated Mitchel Sayare, PhD, Vipin Garg, PhD, David Drutz, MD, John M. Gill, Philip Hodges, Diane Jorkasky, MD, Wayne Pisano, Klaus Schafer, MD, and Catherine Sohn, PharmD, to be elected to serve as directors. The corporation's bylaws require that a stockholder provide advance notice to the corporation of a stockholder's intent to nominate persons as directors. No such notice was received. Accordingly, I declare the nominations for directors closed. The board of directors unanimously recommends that the stockholders vote in favor of this proposal. Are there any questions concerning the proposal? Anyone who is voting via the web portal, please mark your vote now.
The second item of business is the ratification of the appointment of Ernst & Young LLP as the corporation's independent registered public accounting firm for the fiscal year ending December 31, 2023. The Audit Committee of the Board of Directors, which is comprised entirely of independent directors, appointed Ernst & Young as the corporation's independent registered public accounting firm to audit the corporation's financial statements for the fiscal year ending December 31, 2023. The board of directors approved the selection of Ernst & Young LLP and has asked the stockholders to ratify the selection. The stockholder ratification is not required by the corporation's bylaws. However, the board of directors is submitting this to the stockholders for ratification as a matter of good corporate governance.
If the stockholders do not approve the selection of Ernst & Young LLP as the corporation's independent registered public accounting firm, the Board of Directors and the Audit Committee will reconsider the appointment. Are there any questions regarding the proposal? Anyone who is voting via the web portal, please mark your vote now. The third item of business is the approval on an advisory basis of the compensation of the corporation's named executive officers as disclosed in the Proxy Statement. The Board of Directors unanimously recommends that stockholders vote in favor of this proposal. Are there any questions concerning the proposal? Anyone who is voting via the web portal, please mark your vote now. The fourth item of business is the approval on an advisory basis of the frequency of future advisory votes on the compensation of the corporation's named executives. Are there any questions concerning the proposal?
Anyone who is voting via the web portal, please mark your vote now. The fifth item of business is the approval of the authorization to adjourn the annual meeting, if necessary or appropriate, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the proposals. The Board of Directors unanimously recommends that stockholders vote in favor of this proposal. Are there any questions concerning the proposal? Anyone who is voting via the web portal, please mark your vote now. You must submit your ballot via the web portal now in order for your vote to be counted. The Inspector of Election will not accept ballots, proxies, or votes, or any changes or revocations submitted after the closing of the polls.
It is now 8:39 A.M. on September 28th, 2023, and the polls for each matter to be voted on at this meeting are now closed. No additional ballots, proxies, or votes and no changes or revocations will be accepted. Mrs. Figueroa, please report on the results of the voting.
With regard to Proposal One, a plurality of the shares present or represented and entitled to vote has been voted in favor of the election of the persons nominated. With regard to Proposal Two, a majority of the shares present or represented and entitled to vote has been voted in favor of the ratification of Ernst & Young LLP as the corporation's independent registered accounting firm for the fiscal year ending December 31, 2023. With regard to Proposal Three, a majority of the shares present or represented and entitled to vote has been voted in favor of the approval on an advisory basis of the compensation of the corporation's named executive officers as disclosed in the proxy statement.
With regard to Proposal Four, a majority of the shares present or represented and entitled to vote has been voted in favor of the approval on an advisory basis of the frequency of advisory votes for the compensation of the corporation's named executive officers to be once a year. With regard to Proposal Five, a majority of the shares present or represented and entitled to vote has been voted in favor of the approval of the authorization to adjourn the annual meeting if necessary or appropriate, to solicit additional proxies in favor of the foregoing proposal, if there are not sufficient votes to approve the proposals.
Thank you, Mrs. Figueroa. I declare that all the proposals presented at the meeting have been overwhelmingly ratified or approved by the stockholders. The final results of voting, including any ballots and proxies recorded during this meeting, will be set forth in the report of the Inspector of Election and will be included in the minutes of the meeting. The final results will also be included in our reports filed with the SEC. There being no other matters for consideration at this meeting, I hereby adjourn the meeting.